Doubling of Radical Surgery Rates for High-Risk Prostate Cancer Reported
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
By 2016, radical prostatectomy use nearly equaled radiation therapy use for high-risk prostate cancer.
The authors of a new review discuss priorities, adjustments, and tailored approaches to prostate cancer management during the COVID-19 pandemic.
According to researchers, 57.3% of men who underwent salvage robot-assisted radical prostatectomy were pad-free at 12 months.
Two-year recurrence-free survival was 100% vs 95.2% among robotic surgery and radiofrequency ablation patients, respectively.
Radical prostatectomy centers that closed from ’10 to ’14 more likely in areas with strong competition.
A new review shows no significant differences in oncologic outcomes, long-term complications, and health-related quality of life between robot-assisted and open radical cystectomy.
The researchers found lower overall survival among patients undergoing robot-assisted radical cystectomy at hospitals performing 10 or fewer procedures during 2010 to 2012.
Patients with longer hospital stays and pre-discharge complications were at increased risk of readmission within 30 days of discharge.
No benefit of autologous urethral sling placement at robotic assisted radical prostatectomy on early return of continence at 6 months.
In 2013, nearly one third of all minimally invasive radical nephrectomies were performed with robotic assistance.